Exane Derivatives Moderna, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Moderna, Inc. stock. As of the latest transaction made, Exane Derivatives holds 4,267 shares of MRNA stock, worth $113,331. This represents 0.39% of its overall portfolio holdings.
Number of Shares
4,267
Previous 3,917
8.94%
Holding current value
$113,331
Previous $674,000
9.64%
% of portfolio
0.39%
Previous 0.21%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
873Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$679 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$663 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$472 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$198 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...